| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/27/2007 | US7183095 Cell culture system for synthesis of infectious hepatitis C virus |
| 02/22/2007 | WO2007022425A2 Influenza recombinant subunit vaccine |
| 02/22/2007 | WO2007020017A1 Composition for bird immunization administered by aerosol |
| 02/22/2007 | WO2004048543A3 Methods and compositions for controlling valency of phage display |
| 02/22/2007 | US20070042494 Heterologous retroviral packaging system |
| 02/22/2007 | US20070042462 Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb |
| 02/22/2007 | US20070042356 Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
| 02/22/2007 | US20070042002 Influenza recombinant subunit vaccine |
| 02/22/2007 | US20070042001 Influenza recombinant subunit vaccine |
| 02/22/2007 | US20070042000 Porcine reproductive and respiratory syndrome vaccine based on isolate ja-142 |
| 02/22/2007 | US20070041999 Production of multivalent virus like particles |
| 02/22/2007 | US20070041946 Serotype of adenovirus and uses thereof |
| 02/22/2007 | US20070041943 Expression of virus entry inhibitors and recombinant AAV thereof |
| 02/22/2007 | CA2656705A1 Influenza recombinant subunit vaccine |
| 02/21/2007 | EP1754789A2 Bacillus strains and pesticidal proteins |
| 02/21/2007 | EP1754787A2 Methods for producing members of specific binding pairs |
| 02/21/2007 | EP1438066B1 Incapacitated whole-cell immunogenic bacterial compositions |
| 02/21/2007 | EP1423543B1 Detection of bovine viral diarrhea virus in tissue samples |
| 02/21/2007 | EP1180167B1 In vivo selection method for determining inhibitory rna molecules |
| 02/21/2007 | EP1071827B1 Mixed cell diagnostic systems |
| 02/21/2007 | EP0901523B1 Immortalized avian cell lines |
| 02/21/2007 | CN1918288A Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and essays for making and using |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179473 Attenuated pestiviruses |
| 02/20/2007 | US7179457 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging |
| 02/20/2007 | CA2193210C Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 02/15/2007 | WO2007019250A1 Virus-interacting layered phyllosilicates and methods of inactivating viruses |
| 02/15/2007 | WO2007019094A2 Modified influenza virus for monitoring and improving vaccine efficiency |
| 02/15/2007 | WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus |
| 02/15/2007 | WO2006094756A3 Varicella zoster virus vaccine |
| 02/15/2007 | WO2005113059A3 Disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 02/15/2007 | US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070036827 West nile virus vaccine |
| 02/15/2007 | US20070036826 Influenza immunogen and vaccine |
| 02/15/2007 | US20070036760 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 02/15/2007 | US20070036758 Mutants of vaccinia virus as oncolytic agents |
| 02/15/2007 | DE102005037824A1 Reduction of virus infection in a biological process comprises using chemical and/or physical methods that possess no or only minimal virus inactivation capacity and exposing the pre-treated process to shearing stress to clear inactivation |
| 02/15/2007 | CA2621346A1 Virus-interacting layered phyllosilicates and methods of inactivating viruses |
| 02/14/2007 | EP1752468A1 Method for the production of empty viral capsids in yeasts, said capsids comprising proteins derived from pvp2 of the virus that causes infectious bursal disease (ibdv) |
| 02/14/2007 | EP1751289A1 Tc-83-derived alphavirus vectors, particles and methods |
| 02/14/2007 | EP1751282A2 Production of host cells containing mutiple integrating vectors by serial transduction |
| 02/14/2007 | EP1751276A1 Vaccine comprising an attenuated pestivirus |
| 02/14/2007 | EP1751275A1 Compositions and methods to prevent aav vector aggregation |
| 02/14/2007 | EP1751186A2 Carrier conjugates of tnf-peptides |
| 02/14/2007 | EP1206495B1 Chimeric polypeptides, method for production and uses thereof |
| 02/14/2007 | EP0948601B1 Methods for purifying viruses |
| 02/14/2007 | CN1914314A Method of producing virus |
| 02/14/2007 | CN1913920A Influenza immunogen and vaccine |
| 02/14/2007 | CN1912112A Recombinant infectious non-segmented negative strand rna virus |
| 02/14/2007 | CN1911445A Grippe primary generation susliks kidney cell multivalent raccine and its preparation method |
| 02/14/2007 | CN1300321C Survivin mutant recombinant adenovirus with tumour cell death-promoting function and method for obtaining same |
| 02/14/2007 | CN1300307C Recombined T4 bacteriophage of expressing cholecystokinin gene |
| 02/13/2007 | US7176286 Antigen fragments for the diagnosis of Toxoplasma gondii |
| 02/13/2007 | US7176021 Mutant cells with altered sialic acid |
| 02/13/2007 | US7176020 Detection and monitoring anticarcinogenic agents; obtain tissue, infect with cancer cells, incubate with test compound, monitor antiproliferative activity |
| 02/13/2007 | US7175984 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070031878 Methods and compositions for polypeptide engineering |
| 02/08/2007 | US20070031453 Modified influenza virus for monitoring and improving vaccine efficiency |
| 02/08/2007 | US20070031383 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 02/07/2007 | EP1749885A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
| 02/07/2007 | EP1749098A2 Chimeric adenoviruses for use in cancer treatment |
| 02/07/2007 | EP1748790A2 Multi plasmid system for the production of influenza virus |
| 02/07/2007 | EP1194580B1 In vitro reconstitution of segmented negative-strand rna viruses |
| 02/07/2007 | CN1910276A Chimeric empty capsids of the infectious bursal disease virus (IBDV), obtainment process and applications |
| 02/07/2007 | CN1910275A Compositions comprising fetal liver cells and methods useful for HCV infection |
| 02/07/2007 | CN1909923A Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 02/07/2007 | CN1298845C Recombinant Newcastle disease LaSota low virulent vaccine strain expressing bird flu virus H5 subtype HA protein |
| 02/07/2007 | CN1298738C Modified morbillivirus V proteins |
| 02/06/2007 | US7173106 Potent and highly specific insecticidal toxin comprising 45 residues and three intramolecular disulfide bonds; method for selecting potent inhibitors of insect calcium channels |
| 02/06/2007 | US7172899 A recombinant mammalian cell that expresses a mammalian adenovirus E1 functional protein and comprises a porcine circovirus genome |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172870 Treatment of papillomavirus infections |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2236113C Negative strand rna viral vector having autonomous replication capability |
| 02/01/2007 | WO2006132605A3 Porcine circovirus type 2 vaccines |
| 02/01/2007 | WO2006017206A3 Flavivirus vaccine |
| 02/01/2007 | WO2005116258A3 Influenza hemagglutinin and neuraminidase varians |
| 02/01/2007 | US20070026521 Polynucleotides for use in recombinant adeno-associated virus virion production |
| 02/01/2007 | US20070026425 Hepatitis C virus Non-structural NS3/4A fusion gene |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026016 site-directed mutagenesis; immunogens; vaccines |
| 02/01/2007 | US20070026009 Using influenza virus peptide as tool in diagnosis and treatment of viral diseases |
| 02/01/2007 | US20070026003 Monoclonal antibodies; HCV enveloped subviral or purified HCV enveloped complete viral particles; hybridoma |
| 02/01/2007 | US20070025981 Microorganisms for therapy |
| 02/01/2007 | US20070025971 Substances causing differentiation |
| 02/01/2007 | US20070025970 Vector system |
| 02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 01/31/2007 | EP1747268A1 Process for the production of an influenza vaccine |
| 01/31/2007 | EP1747267A1 Apparatus for the disruption of animal cells |
| 01/31/2007 | EP1747013A2 Lipid-extracted therapeutic vaccine and method of use |
| 01/31/2007 | EP1746877A2 Regulation of transcription with a cis-acting ribozyme |
| 01/31/2007 | EP1392838B1 Pseudotyping of hiv vectors with mokola virus envelopes |
| 01/31/2007 | EP1034000B1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral hiv infection |
| 01/31/2007 | CN1905903A Ghrelin-carrier conjugates |
| 01/31/2007 | CN1904056A Recombinant adeno-associated virus comprising VEGFR Truncated Soluble cDNA and gene therapeutic agent comprising the same |
| 01/31/2007 | CN1904055A Targeted liposome gene delivery |
| 01/31/2007 | CN1297314C Method for cultivating attenuated strain pilio inactivated vaccine |
| 01/31/2007 | CN1297313C After treatment method for attenuated strain polio inactivated vaccine |